Endoscopic sleeve gastroplasty – where we are and where we are heading

Česká verzia

Authors: Jan Král ¹ ; E. Machytka ^2,3
Authors place of work: Interní klinika 2. LF UK, a FN v Motole, Praha ¹; II. interni klinika LF MU, a FN u sv. Anny v Brně ²; Endohope klinika s. r. o., Praha ³
Published in the journal: Rozhl. Chir., 2024, roč. 103, č. 9, s. 331-335.
Category: Review
doi: https://doi.org/10.48095/ccrvch2024331

Summary

Obesity is a global problem with a rising prevalence, which has serious implications not only for individuals‘ health but also for society as a whole. The increased incidence of overweight and obesity leads to higher healthcare costs and limits the employment opportunities of individuals, affecting their quality of life.

The treatment of obesity encompasses various approaches, including diet, exercise, pharmacotherapy, and surgical bariatric procedures. New and promising methods of treatment include endoscopic sleeve gastroplasty (ESG). ESG offers a safe, minimally invasive method that reduces the volume of the stomach and has long-term results in terms of weight reduction.

Thanks to significant advances in the field of endoscopy and endoscopic suturing, we can expect new and improved devices to be used in ESG. This will make ESG even safer, less dependent on the expertise of physicians, and its outcomes will significantly approach those of traditional bariatric surgery.

Keywords:

obesity – endoscopy – bariatrics

Zdroje

1. Yumuk V, Tsigos C, Fried M et al. European guidelines for obesity management in adults. Obes Facts 2015; 8(6): 402–424. doi: 10.1159/000442721.

2. Eurostat Statistics Explained. Overweight and obesity – BMI statistics. [online]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Overweight_and_obesity_-_BMI_statistics.

3. CDC. Adult Obesity Facts 2020. [online]. Available from: https://www.cdc.gov/obesity/php/data-research/adult-obesity-facts.html.

4. Ward ZJ, Bleich SN, Cradock AL et al. Projected U.S. State-level prevalence of adult obesity and severe obesity. N Engl J Med 2019; 381(25): 2440–2450. doi: 10.1056/NEJMsa1909301.

5. World Health Organization. Obesity and overweight. [online]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

6. Česká lékařská společnost Jana Evangelisty Purkyně. Obezita v České republice. [online]. Available from: https://www.nzip.cz/clanek/728-obezita-v-ceske-republice.

7. Státní zdravotní ústav. Studie Zdraví dětí 2016. [online]. Available from: https://szu.cz/tema/studie-zdravotniho-stavu-obyvatelstva/deti/studie-2016/.

8. Okunogbe A, Nugent R, Spencer G et al. Economic impacts of overweight and obesity: current and future estimates for eight countries. BMJ Glob Health 2021; 6(10): e006351. doi: 10.1136/bmjgh-2021-006351.

9. Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019; 15(5): 288–298. doi: 10.1038/s41574-019-0176-8.

10. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med 2017; 376(3): 254–266. doi: 10.1056/NEJMra1514009.

11. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012; 142(4): 711–725.e6. doi: 10.1053/j.gastro.2012.02.003.

12. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002; 346(8): 591–602. doi: 10.1056/NEJMra012586.

13. Eldar S, Heneghan HM, Brethauer SA et al. Bariatric surgery for treatment of obesity. Int J Obes 2011; 35(Suppl 3): S16–S21. doi: 10.1038/ijo.2011.142.

14. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Med Clin North Am 2011; 95(5): 1009–1030. doi: 10.1016/j.mcna.2011.06.010.

15. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393–403. doi: 10.1056/NEJMoa012512.

16. Jung SH, Yoon JH, Choi HS et al. Comparative efficacy of bariatric endoscopic procedures in the treatment of morbid obesity: a systematic review and network meta-analysis. Endoscopy 2020; 52(11): 940–954. doi: 10.1055/a-1149-1862.

17. Barrichello S, Hourneaux de Moura DT, Hourneaux de Moura EG et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointest Endosc 2019; 90(5): 770–780. doi: 10.1016/j.gie.2019.06.013.

18. Lopez-Nava G, Galvao MP, Bautista-Castano I et al. Endoscopic sleeve gastroplasty for obesity treatment: two years of experience. Arq Bras Cir Dig 2017; 30(1): 18–20. doi: 10.1590/0102-6720201700010006.

19. Abu Dayyeh BK, Bazerbachi F, Vargas EJ et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet 2022; 400(10350): 441–451. doi: 10.1016/S0140-6736(22)01280-6.

20. Huberty V, Boskoski I, Bove V et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut 2020; gutjnl-2020-3222026. doi: 10.1136/gutjnl-2020-322026.

21. Sharaiha RZ, Hajifathalian K, Kumar R et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol 2021; 19(5): 1051–1057.e2. doi: 10.1016/j.cgh.2020.09.055.

22. Gkolfakis P, Van Ouytsel P, Mourabit Y et al. Weight loss after endoscopic sleeve gastroplasty is independent of suture pattern: results from a randomized controlled trial. Endosc Int Open 2022; 10(9): E1245–E1253. doi: 10.1055/a-1880-7580.

23. Fayad L, Cheskin LJ, Adam A et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy 2019; 51(6): 532–539. doi: 10.1055/a-0852-3441.

24. Singh S, de Moura DTH, Khan A et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg 2020; 30(8): 3010–3029. doi: 10.1007/s11695-020-04644-8.

25. Beran A, Matar R, Jaruvongvanich V et al. Comparative effectiveness and safety between endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a meta-analysis of 6775 individuals with obesity. Obes Surg 2022; 32(11): 3504–3512. doi: 10.1007/s11695-022-06254-y.

26. Thompson CC, Jirapinyo P, Shah R et al. Gastroplasty with endoscopic myotomy (GEM) for the treatment of obesity: preliminary efficacy and physiologic results. Gastroenterology 2022; 163(5): 1173–1175. doi: 10.1053/j.gastro.2022.07.077.

27. Tysoe O. Endoscopic sleeve gastroplasty: safe and effective. Nat Rev Endocrinol 2022; 18(10): 589. doi: 10.1038/s41574-022-00739-7.

MUDr. Jan Král, Ph.D., MBA

Interní klinika

2. LF UK a FN v Motole

V Úvalu 84

150 06 Praha 5

jan.kral@centrum.cz